Quoin Pharmaceuticals, Ltd. Profile
Industry
BiotechnologySector
HealthcareNumber of Employees
4Quoin Pharmaceuticals Ltd.'s Business Model
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
About Quoin Pharmaceuticals Ltd.
Website: https://quoinpharma.com
CEO (Chief Executive Officer): Dr. Michael Myers Ph.D.
IPO date: 2016-08-01
Contact
Country: US
Address: 42127 Pleasant Forest Court
City: Ashburn
State: VA
Phone: 703 980 4182
Zip Code: 20148-7349
Other
CIK: 0001671502
ISIN: US74907L3006
CUSIP: 74907L102
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
